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Abstract
Backgound: The identification of B-cell epitopes on antigens has been a subject of intense research as the
knowledge of these markers has great implications for the development of peptide-based diagnostics, therapeutics
and vaccines. As experimental approaches are often laborious and time consuming, in silico methods for prediction
of these immunogenic regions are critical. Such efforts, however, have been significantly hindered by high
variability in the length and composition of the epitope sequences, making naïve modeling methods difficult
to apply.
Results: We analyzed two benchmark datasets and found that linear B-cell epitopes possess distinctive residue
conservation and position-specific residue propensities which could be exploited for epitope discrimination in silico.
We developed a support vector machines (SVM) prediction model employing Bayes Feature Extraction to predict
linear B-cell epitopes of diverse lengths (12- to 20-mers). The best SVM classifier achieved an accuracy of 74.50%
and AROC of 0.84 on an independent test set and was shown to outperform existing linear B-cell epitope
prediction algorithms. In addition, we applied our model to a dataset of antigenic proteins with experimentally-
verified epitopes and found it to be generally effective for discriminating the epitopes from non-epitopes.
Conclusion: We developed a SVM prediction model utilizing Bayes Feature Extraction and showed that it was
effective in discriminating epitopes from non-epitopes in benchmark datasets and annotated antigenic proteins.
A web server for predicting linear B-cell epitopes was developed and is available, together with supplementary
materials, at http://www.immunopred.org/bayesb/index.html.
Background
Humoral immune responses play critical roles in the
body’s defense against pathogens and foreign agents, as
well as certain hypersensitivity reactions [1]. The princi-
pal agents of the humoral immune responses are the
B lymphocytes (B-cells). Naïve B-cells are stimulated by
specific recognition and binding of the B-cell receptor
to a region on the antigen called the epitope. Together
with co-stimulation from the T lymphocytes (T-cells),
naïve B-cells become fully activated and go on to prolif-
erate and differentiate into memory and plasma cells,
with the latter serving as the key engines for producing
specific antibodies. The identification and mapping of
B-cell epitopes on antigens has been a subject of intense
research as the knowledge of these markers has pro-
found implications for the development of peptide-
based diagnostics, therapeutics and vaccines. B-cell epi-
topes may comprise of linear, contiguous stretches of
amino acids within a protein, or they can be discontinu-
ous stretches of amino acids that are brought together
spatially by protein folding. Although the majority of
B-cell epitopes are discontinuous in nature, difficulties
in the design of such epitopes have led to an emphasis
on the identification of linear B-cell epitopes. As experi-
mental efforts for linear B-cell epitope identification is
often laborious and expensive, much effort has been
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prediction.
The pioneering methods for linear B-cell epitope pre-
diction were based on correlations between several phy-
sicochemical properties of amino acids and the locations
of the epitopes on antigens. Computational methods
such as PREDITOP [2], PEOPLE [3], BEPITOPE [4] and
BcePred [5] implemented a variety of physicochemical
propensity scales, such as hydrophilicity, flexibility or
solvent accessibility, in their prediction models. How-
ever, Blythe and Flower [6] conducted an extensive
investigation of the utility of these physicochemical pro-
pensity scales for predicting linear B-cell epitopes and
concluded that even the best set of scales and para-
meters performed only marginally better than random
and the reported performance of these methods were
likely to be overly optimistic. Interestingly, several meth-
ods based on machine learning algorithms were
explored thereafter and were shown to improve predic-
tion performance over the earlier methods: Larson et al.
[7] developed BepiPred which uses two amino acid pro-
pensity scales and hidden markov models (HMM);
Sollner and Mayer [8] utilized decision trees and the
nearest-neighbor method; and Saha and Raghava [9]
experimented with artificial neural networks. More
recently, various groups have shown improved predic-
tion performance with the use of the support vector
machines (SVM) algorithm. Chen et al. [10] found that
certain amino acid pairs were found to occur more fre-
quently in B-cell epitopes and developed a SVM method
b a s e do na m i n oa c i dp a i r sp r o p ensities, achieving the
best accuracy value of 71%. EL-Manzalawy et al. [11]
reported superior performance over previous methods
when they utilized string kernels in the SVM algorithm,
achieving the highest AROC (area under the receiver
operating characteristic curve) score of 0.758. COBEpro
utilized unique feature representations of epitope
sequences in the SVM algorithm and realized an AROC
of 0.829 [12]. In addition, Rubinstein et al.[13,14] devel-
oped a comparatively accurate model for predicting
immunogenic regions on a protein’s three dimensional
structure or sequence using the Naïve Bayes classifier.
In this paper, B-cell epitopes and non-epitopes from
benchmark datasets were analyzed to identify unique
sequence characteristics which can be exploited for epi-
tope discrimination. We observed that specific amino
acids were unusually enriched or depleted in epitopes
compared to non-epitopes. Moreover, epitopes were
found to possess unique patterns of position-specific
residue propensities. We developed a SVM prediction
model utilizing Bayes Feature Extraction and predicted
linear B-cell epitopes of diverse lengths (12- to 20-
mers). The model was found to achieve superior results
when compared to other existing methods. The best
SVM classifier achieved an accuracy of 74.50% (sensitiv-
ity of 81%, specificity of 68%) and AROC of 0.84 when
tested on an independent dataset. In addition, the model
was tested on dataset of experimentally verified antigens
with annotated epitopes and was found to be generally
effective in discriminating the epitopes from non-
epitopes. The prediction model is implemented on a
web server, BayesB, which can be freely accessed at
http://www.immunopred.org/bayesb/index.html.
Results and Discussion
Sequence analysis of linear B-cell epitopes
Accurate in silico prediction of linear B-cell epitopes is a
highly desirable goal as it is often the important first step
in computational mapping of epitopes on pathogen pro-
teins and in the design of immuno-diagnostics and vac-
cine development. Much of the existing work has been
centered on the use of raw sequence information as well
as the innate physicochemical properties of the sequences
as represented by a multitude of amino acid propensity
scales. While Blythe and Flower have shown that the use
of such propensity scales by themselves offer limited pre-
dictive capabilities and do not significantly improve pre-
diction accuracy, recent methods involving machine
learning algorithms suggest that incorporating such
information into more complex, non-linear models might
be helpful. Interestingly, while different feature represen-
tations were applied to predict linear B-cell epitopes,
there are only limited insights on the use of residue con-
servation and position-specific amino acid profiles for
prediction. As these features were found to be useful for
improving prediction accuracy in several related biologi-
cal domains [15-17], it is intuitive to question if these fea-
tures are similarly prominent in linear B-cell epitopes and
could be exploited to enhance the performance of
machine learning-based prediction models.
We conducted a series of analyses on epitope
sequences using benchmark datasets from EL-Manza-
lawy et al.[11] and Chen et al.[10] (henceforth termed
as EL-Manzalawy and Chen datasets respectively). Both
datasets contain linear B-cell epitope sequences derived
from Bcipep [18]. From both datasets, we extracted 20-
mer epitope and non-epitope peptides for our analyses.
Our choice of 20-mer peptides is based on the fact that
most epitopes (~86%) in both datasets are 20 amino
acids or shorter in length, with 20-mer peptides being
found in the greatest proportion. A sizeable number of
shorter epitopes are also enclosed within the longer 20-
mer peptides. In addition, 20-mer peptides were widely
used in earlier algorithmic development so the usage of
these peptides would be convenient for comparative
analyses [10,11].
Next, we constructed an analysis subset containing a
pool of 20-mer epitopes and an equivalent-sized pool of
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An analysis subset was also constructed from Chen
dataset in the same manner. To further validate the ana-
lyses, we constructed two control subsets from EL-
Manzalawy and Chen datasets respectively. The control
subsets contain only non-epitopes data which is divided
into two pools of equal numbers each. For both analysis
and control subsets, we calculated the relative position-
specific propensities of each amino acid (Px)a tt w e n t y
residue positions on the 20-mer peptides. For the analy-
sis subsets, Px indicates the relative frequency of a
particular amino acid in the epitopes pool over the
frequency of the same amino acid in the non-epitopes
pool at the same position. For the control subsets, Px
values were calculated in t h es a m em a n n e rb u tu s i n g
the two pools of non-epitopes. Px values were plotted as
heat maps to facilitate visualization (Figure 1). For the
EL-Manzalawy dataset (Figure 1, left top and bottom),
several amino acids were found to have very distinctive
Px scores in the analysis subset compared to the control
subset. Across the entire length of the 20-mer peptides,
tryptophan (W), proline (P), glutamine (N) were found
to be relatively enriched in epitopes, with the average Px
of 2.16, 1.59 and 1.24 respectively (Table of average Px
Figure 1 Heat maps of relative position-specific amino acid propensities (Px). Px values of amino acids were computed for EL-Manzalawy
analysis and control subsets (left, top and bottom respectively) and Chen analysis and control subsets (right, top and bottom respectively). Px
values were computed as the ratio of the frequency of occurrence of the amino acid in the epitopes pool over the frequency of occurrence of
the same amino acid in the non-epitopes pool at a specific position. Px values were calculated using the epitopes and non-epitope pools in the
analysis subsets, and using the two pools of non-epitopes in the control subsets. Increasing color intensities in the red spectrum indicate
enrichment in epitopes pool (high Px) while increasing color intensities in the blue spectrum indicate enrichment in non-epitopes pool (low Px).
Wee et al. BMC Genomics 2010, 11(Suppl 4):S21
http://www.biomedcentral.com/1471-2164/11/S4/S21
Page 3 of 9scores for amino acids across whole peptide length is
provided in Additional file 1). On the other hand, phe-
nylalanine (F) and leucine (L) were found to be relatively
depleted in epitopes with the average Px of 0.77
and 0.80 respectively. Similarly, for the Chen dataset
(Figure 1, right top and bottom), W, P and N were
found to be relatively enriched in epitopes with the
average Px of 1.50, 1.57 and 1.22 respectively while F
and L residues were observed to be relatively depleted
in epitopes with average Px of 0.77 for both.
As certain amino acids are distinctly conserved in epi-
topes, we further questioned if there are patterns of
position-specific conservation of residues that are
unique among the epitopes. To this end, we compared
the standard deviations of Px of all amino acids at each
position along the 20-mer peptides in the analysis and
control subsets. It could be reasoned that higher varia-
bility of relative position-specific propensities of amino
a c i d si ne p i t o p e si si n d i c a t ive of distinct and perhaps
complex patterns of position-specific conservation of
residues. Indeed, for the EL-Manzalawy dataset (Figure 2,
top), the standard deviations of Px were notably greater
for 75% (15/20) of the residue positions for peptides in
the analysis subset compared to the control subset. For
the Chen dataset (Figure 2, bottom), 50% (10/20) of all
residue positions were found to have greater standard
Figure 2 Quantitative measurement of the spread between the relative position-specific amino acid propensities (Px) at various
residue positions in analysis and control subsets. At each residue position, standard deviations of Px of all amino acids were calculated.
Standard deviation scores were plotted against analysis and control subsets for EL-Manzalawy (top) and Chen (bottom) datasets.
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control subset. These results indicate that there might
be complex patterns of position-specific residue propen-
sities in epitope sequences which could be exploited
further to enhance computational prediction.
SVM-based prediction with Bayes Feature Extraction
To encapsulate these complex patterns of residue con-
servation and position-specific propensities for compu-
tational prediction, we constructed SVM prediction
models using features extracted using the Bayes Fea-
ture Extraction (BFE) approach recently introduced by
Shao et al.[19]. BFE was shown to significantly
improve prediction of protein methylation sites [19]
and caspase cleavage sites [20] over using simple bin-
ary encoding schemes. Essentially, in the application of
B F E ,f e a t u r ev e c t o r sa r ee n c o d e di nab i - p r o f i l em a n -
ner containing attributes from positive position-specific
and negative position-specific profiles. These profiles
are generated through calculating the frequency of
occurrence of each amino acid at each position of the
peptide sequence in the epitopes pool and non-
epitopes pool respectively. We tested our SVM predic-
tion model using the EL-Manzalawy dataset which is
suggested to be more appropriately suited for benchmark-
ing purposes as it is comprised of homology-reduced epi-
tope sequences. We constructed SVM classifiers for
peptides of diverse lengths from the EL-Manzalawy dataset
(12- to 20-mers) using simple binary encoding or BFE
schemes (detailed in the Materials and Methods).
Sequences were partitioned respectively into training and
independent test sets. 10-fold cross-validation was con-
ducted on training sets to obtain the optimal set of SVM
parameters (results and choice of optimal parameters are
detailed in Additional file 2). The SVM classifiers are
trained on the entire training set using the optimized para-
meters and evaluated for their performances on the inde-
pendent test sets. As shown in Table 1, simple binary
encoding schemes were shown to achieve mediocre per-
formances as accuracy and AROC scores of all peptide
lengths (represented as SVM12, SVM14, SVM16, SVM18
and SVM20 respectively) were consistently below 60% and
0.70 respectively. However, when simple binary encoding
schemes were replaced with BFE (represented as BFE-
SVM12, BFE-SVM14, BFE-SVM16, BFE-SVM18 and BFE-
SVM20 respectively), significant improvements were
attained across all peptide lengths. In these cases, accuracy
and AROC scores for each peptide length were consis-
tently higher than those obtained from classifiers trained
using simple binary encoding schemes, with the best clas-
sifier (BFE-SVM20) achieving an accuracy of 74.50%, sen-
sitivity of 81%, specificity of 68% and AROC of 0.84
Next, we compared our SVM prediction model with
algorithms developed by EL-Manzalawy et al.[11],
Sweredoski and Baldi [12] and Chen et al.[10], as they
are among the best performing algorithms in this
domain. Since the EL-Manzalawy dataset was utilized in
some of these algorithms, it was relatively convenient to
perform benchmark comparisons with our model. In
EL-Manzalawy et al.[11], the SVM classifier trained on
the 20-mer peptide dataset using string kernels was
found to achieve overall accuracy of 67.90% and AROC
of 0.758 on five-fold cross-validation. For classifiers
trained on the 12- to 18-mer datasets, AROC scores ran-
ged from 0.709 to 0.751. Interestingly, in our prediction
model, AROC scores were similarly observed to improve
generally as the length of the peptide increases for both
representation schemes. It was suggested that many of
the shorter epitopes are part of the longer epitopes and
the presence of additional amino acids flanking the
shorter epitopes might assist the classifier in discrimi-
nating the epitopes from non-epitopes [11]. In Swere-
doski and Baldi [12], the SVM classifier trained on the
same EL-Manzalawy dataset using a proprietary feature
extraction scheme achieved accuracy and AROC of 71.4%
and 0.768 respectively on five-fold cross-validation.
Chen et al.[10] reported accuracy of 71.0% on five-fold
cross-validation using amino acid pair antigenicity pro-
pensities and SVM. To benchmark against Chen et al.
[10], we tested our model using the Chen dataset (20-
mers) and achieved accuracy and AROC scores of 68.50%
and 0.74 respectively (Table 1, BFE-Chen). While it
appears that our SVM implementation using Chen data-
set performed slightly poorer when compared to the
corresponding test on EL-Manzalawy dataset (BFE-
SVM20) and with Chen et al.[10], we reasoned that this
was due to the relatively higher proportion of similar
sequences in the Chen dataset compared to the EL-
Manzalawy dataset.
Table 1 Results of SVM prediction on independent
test sets
SVM
Classifier*
Sensitivity
(%)
Specificity
(%)
Accuracy
(%)
AROC
SVM12 59.00 54.00 56.50 0.60
SVM14 60.00 51.00 55.50 0.62
SVM16 62.00 47.00 54.50 0.59
SVM18 62.00 57.00 59.50 0.67
SVM20 54.00 62.00 58.00 0.64
BFE-SVM12 70.00 64.00 67.00 0.71
BFE-SVM14 63.00 69.00 66.00 0.73
BFE-SVM16 73.00 62.00 67.50 0.73
BFE-SVM18 70.00 69.00 69.50 0.80
BFE-SVM20 81.00 68.00 74.50 0.84
BFE-Chen 70.00 67.00 68.50 0.74
*SVM classifiers are generated for different peptide lengths as indicated by
the numerical value assigned to each classifier.
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discriminate epitopes from non-epitopes, we applied the
BFE-SVM20 classifier to predict linear B-cell epitopes
on 14 antigen sequences derived from a dataset curated
by Pellequer et al.[2,7] (henceforth termed as Pellequer
dataset). We have chosen to apply the BFE-SVM20 clas-
sifier as it was shown to achieve the best performance
in our earlier validation. Antigen sequences were
scanned using a 20-mer sliding window and each 20-
mer peptide was predicted as an epitope or not. The
prediction outputs were integrated and re-computed as
a residue epitope propensity score, Ep for each residue
on the antigen where residues with Ep > 0 were assigned
as epitopes and Ep ≤ 0 were assigned as non-epitopes. In
this representation, every residue on the antigen
sequence is scored for its propensity to be an epitope or
non-epitope. This facilitates the identification of epi-
topes of different lengths on antigen sequences as well
as regions which might be epitope-rich. As shown in
Table 2, the use of residue epitope propensity scores
was able to achieve above 50% accuracy for most of the
antigens (11/14) and above 70% accuracy for four anti-
gens. In addition, from our analysis of the residue epi-
tope propensity scores on all antigens (data not shown),
we noted that experimentally annotated epitopes had
generally higher Ep scores compared to non-epitopes
(1.53 versus -0.23 respectively, P-value <0.1).
In summary, we showed that SVM-based prediction
using Bayes Feature Extraction is an effective method
for predicting linear B-cell epitopes. By using a set of
benchmark datasets, this method was observed to per-
form better than several of the best existing methods.
Also, by scoring experimentally-verified antigen
sequences with residue epitope propensity scores
derived from the SVM prediction outputs, annotated
e p i t o p ea n dn o n - e p i t o p er e g i o n so nt h ea n t i g e n sc o u l d
be discriminated effectively. The application of Bayes
Feature Extraction consistently enhanced SVM predic-
tion across various peptide lengths, suggesting that
more informative representation of conserved sequence
characteristics is facilitated by this approach. In Bayes
Feature Extraction, the encoding of bi-profile feature
vectors assumes that information carried by each residue
is independent of the other residues. Interestingly, in
linear B-cell epitopes, specific di-peptides were found to
be enriched [10], suggesting that the type of amino acid
found at a particular residue position on the epitope
may somewhat be correlated to type of amino acid
found at the adjacent positions. Therefore, it is tempting
to speculate if prediction performance can be improved
if amino acid di-peptides information is factorized
together with Bayes features in the SVM classifier.
These findings also corroborate previous studies on the
use of feature selection methods to improve prediction
performance [15-17]. Interestingly, feature extraction
using the Bayes Feature Extraction approach as imple-
mented here is intuitively similar to the application
of position-specific scoring matrix (PSSM) profiles for
predicting protective linear B-cell epitopes by EL-
Manzalawy et al.[ 2 1 ] .I nt h a ts t u d y ,i tw a ss h o w nt h a t
the Naive Bayes classifier trained using PSSM profiles
significantly outperformed the propensity scale-based
methods and simple binary encoding with SVM in pre-
dicting protective linear B-cell epitopes. Separately, Song
and co-workers observed improved performance when
PSI-BLAST profiles were used as input features to train
SVM classifiers for predicting residue depth and cis/
trans isomerization in proteins [16,17]. It is expected
that future work on feature selection and feature extrac-
tion methods would be helpful here and in related
bioinformatics domains.
Conclusion
In this paper, we analyzed benchmark datasets and
report that linear B-cell epitopes and non-epitope
sequences have distinctive residue composition and
position-specific propensity patterns which could be
used for epitope discrimination in silico. We developed
a SVM prediction model employing Bayes Feature
Extraction to predict linear B-cell epitopes of diverse
lengths. The best SVM classifier achieved an accuracy of
74.50% and AROC of 0.84 on an independent test set
and was shown to perform better than several existing
linear B-cell prediction algorithms. In addition, we
applied our method on a dataset of antigenic proteins
with experimentally-verified epitopes and found it to be
Table 2 SVM prediction of epitopes on antigens in
Pellequer dataset
UniProt
ID
Antigen Accuracy
(%)
P01556 Enterotoxin beta chain precursor (Cholera) 76.74
P00001 Cytochrome c (Human) 53.03
P03138 Major surface antigen precursor (Hepatitis B
virus)
37.32
P01233 Choriogonadotropin beta chain precursor
(Human)
44.09
P01574 Interferon beta precursor (Human) 72.48
P02238 Leghemoglobin A (Soybean) 75.24
P00698 Lysozyme C precursor (Chicken) 66.06
P02247 Myohemerythrin (Themiste zostericola) 61.25
P02185 Myoglobin (Physeter catodon) 66.96
P04127 PAP fimbrial major pilin protein precursor (E.
coli)
58.50
P01112 Transforming protein p21/H-RAS-1 (Human) 83.44
P00797 Renin precursor (Human) 36.68
P01484 Neurotoxin II (Androctonus australis hector) 51.06
P03570 Coat protein (Tobacco mosaic virus) 52.50
Wee et al. BMC Genomics 2010, 11(Suppl 4):S21
http://www.biomedcentral.com/1471-2164/11/S4/S21
Page 6 of 9generally effective for discriminating the epitopes from
non-epitopes. To complement experimental research,
we have implemented our prediction model on a web
server, BayesB, which is freely accessible athttp://www.
immunopred.org/bayesb/index.html.
As publicly available experimental data on B-cell epi-
topes accumulates, we plan to periodically re-train and
r e - e v a l u a t eo u rS V Mp r e d i c t i o nm o d e l .W eh a v ea l s o
begun comparative studies where B-cell epitope predic-
tions of clinically important viral proteomes are cross-
validated with the antigenicity potential of actual
proteome-derived peptides. It is expected that these
studies would provide a richer evaluation of the real-world
performance of our SVM prediction model.
Materials and Methods
Datasets
We obtained two benchmark datasets of linear B-cell
epitopes and non-epitopes from EL-Manzalawy et al.
[11] (henceforth termed as the EL-Manzalawy dataset)
and Chen et al.[10] (Chen dataset). EL-Manzalawy data-
set contained 701 unique, homology-reduced epitopes of
five different peptide lengths (12-, 14-, 16-, 18- and
20-mers) and Chen dataset contained 872 unique
20-mer epitopes. In both datasets, equal numbers of
non-epitope sequences were deposited by the authors
through randomly extracting peptides from sequences in
Uniprot databases [22] while ensuring that none of
them were included among the epitopes.
We constructed an analysis subset containing a pool
of 20-mer epitopes and an equivalent-sized pool of 20-
mer non-epitopes from EL-Manzalawy dataset. An ana-
lysis subset was also constructed from Chen dataset in
the same manner. To further validate the analyses, we
constructed two control subsets from EL-Manzalawy
and Chen datasets respectively. The control subsets con-
tain only non-epitopes data which is divided into two
pools of equal numbers each. Therefore, for the EL-
Manzalawy dataset, the analysis subset comprised of a
pool of 351 epitope and a pool of 350 non-epitope
sequences, while the control subset contained two pools
of non-epitopes with 350 sequences in each. For the
Chen dataset, the analysis subset comprised of a pool of
436 epitope and a pool of 436 non-epitope sequences
while the control subset contained two pools of 436
non-epitopes in each.
For SVM training and testing, peptides from EL-
Manzalawy dataset (12- to 20-mers) were divided into
training and independent test sets which comprised of
601 epitopes/601 non-epitopes and 100 epitopes/100
non-epitopes respectively. Peptides from Chen dataset
(20-mers) were divided into training and independent
test sets which comprised of 736 epitopes/736 non-epi-
topes and 100 epitopes/100 non-epitopes respectively.
Relative position-specific amino acid propensities
The relative position-specific amino acid propensity, Px,
of an amino acid is a quantitative indicator of the pro-
pensity of the amino acid to be found at a particular
position on the epitope. It is defined as the ratio of the
frequency of occurrence of the amino acid in the epi-
topes pool to the frequency of occurrence of the same
amino in the non-epitopes pool at a specific position.
As 20-mer peptides were used, Px values were calculated
for every amino acid at each of the twenty residue posi-
tions and visualized on heat maps. Px values were calcu-
lated using the epitopes and non-epitope pools in the
analysis subsets, and using the two pools of non-epi-
topes in the control subsets. Average Px of a specific
amino acid is calculated by taking the average of all Px
values of that amino acid across all positions on the
20-mer peptides.
Vector encoding schemes
To encapsulate sequence information into a format for
SVM training and testing, the sequences were coded as
input vectors in simple binary format or in a bi-profile
manner using Bayes Feature Extraction. In simple binary
encoding, each amino acid is represented by a
20-dimensional vector, composed of either zero or one
as elements. For example, alanine was represented as
[0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1] and cysteine as
[0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0]. Therefore, in this
case, a 20-mer peptide will encoded by a 400-dimen-
sional vector (20 x 20). For details on bi-profile vector
encoding using Bayes Feature Extraction, readers are
advised to refer to Shao et al.[19]. Briefly, feature vec-
tors are encoded in a bi-profile manner containing attri-
butes from positive position-specific and negative
position-specific profiles. These profiles are generated
through calculating the frequency of occurrence of each
amino acid at each position of the peptide sequence in
the epitopes pool and non-epitopes pool respectively.
Therefore, a 20-mer input peptide will be encoded by a
40-dimensional (20 x 2) feature vector containing infor-
mation on the residues of the peptide in the positive
(epitope) and negative (non-epitope) spaces.
SVM Training and Testing
For SVM implementation, we used the freely download-
able LIBSVM package by Chang and Lin [23]. Details of
the SVM methodology can be obtained from the article
by Burges [24]. In short, SVM is based on the structural
risk minimization principle from statistical learning the-
ory. A set of positive and negative examples can be
represented by the feature vectors xi (i = 1, 2,....N) with
corresponding labels yi Î {+1,-1}. To classify the data,
the SVM trains a classifier by mapping the input sam-
ples, using a kernel function in most cases, onto a high-
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plane that differentiates the two classes with maximal
margin and minimal error. The decision function for
new predictions on unseen examples is given as:
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The variable C serves as the regularization parameter
that controls the trade-off between margin and classifi-
cation error. We used the radial basis function (RBF)
kernel and performed parameter optimization for g,
which determines the capacity of the RBF kernel, and
the regularization parameter C using 10-fold cross-
validation on EL-Manzalawy and Chen training sets
(optimization process is further described in Additional
file 2). In 10-fold cross-validation, the training dataset
was spilt into 10 subsets where one of the subsets was
used as the test set while the other subsets were used
for training the classifier. The trained classifier was
tested using the test set. The process is repeated ten
times using a different subset for testing, hence ensuring
that all subsets are used for both training and testing.
The optimal values of g and C obtained from the opti-
mization processes were used subsequently for training
the entire training sets to create the final SVM classifier
for testing on the independent test sets.
Performance metrics
Various quantitative variables were employed to mea-
sure the effectiveness of the SVM model for predicting
linear B-cell epitopes:
(i) TP, true positives - the number of correctly classi-
fied epitopes.
(ii) FP, false positives - the number of incorrectly clas-
sified non-epitopes.
(iii) TN, true negatives - the number of correctly clas-
sified non-epitopes.
(iv) FN, false negatives - the number of incorrectly
classified epitopes.
Using the variables above, the metrics Sensitivity (Sn)
and Specificity (Sp), which indicate the ability of the pre-
diction model to correctly classify the epitope and non-
epitope sequences respectively, were computed:
S
TP
TP FN
S
TN
TN FP
n
p
=
+
=
+
To provide an indication of the overall performance of
the prediction model, we computed Accuracy (Acc):
A
TP TN
TP FN TN FP
cc =
+
+++
While these metrics are generally indicative of model
performance, they are dependent on the decision thresh-
old. Therefore, a threshold-independent metric, the area
under the receiver operating characteristic curve (AROC)
was computed as well.
Residue epitope propensities and performance evaluation
on Pellequer dataset
We define ‘residue epitope propensity’ or Ep, as a quan-
titative measure of the likelihood of a residue to be part
of an epitope. Ep scores are computed to evaluate the
effectiveness of the prediction model on antigens with
known epitopes. 14 antigens with experimentally verified
epitopes from a dataset derived from Pellequer et al.
[2,7] were scanned by a 20-mer sliding window and pre-
dicted for linear B-cell epitopes using the BFE-SVM20
classifier. SVM output scores from each 20-mer sliding
window were integrated and re-computed as the residue
epitope propensity score, Ep for each residue on the
antigen. Here, Ep of a residue is computed as the addi-
tive sum of the SVM output scores from the prediction
of the 20-mer sliding windows with the residue located
at different positions along the sliding window. The Ep
values were calculated for residues in all antigen
sequences from the 20
th residue up the last 20
th residue.
To measure its effectiveness as a predictive metric, Ep
was benchmarked against the annotated epitopes on the
antigens. Residues with Ep > 0 and annotated as epitope
were assigned as true positives (TP) while residues with
Ep ≤ 0 and not annotated as epitope were assigned as
true negatives (TN). Residues with Ep ≤ 0 and annotated
as epitope were assigned as false negatives (FN) while
residues with Ep > 0 and annotated as non-epitope were
assigned as false positives (FP). To measure prediction
performance, accuracy scores were computed as
described earlier for each antigen using the TN, TN, FN
and FP variables.
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Additional file 1: Average Px of amino acidsDescription of Data:
Average Px of each amino acid is calculated by averaging the Px values
of the particular amino acid across all residue positions on the 20-mer
peptides from analysis and control subsets of EL-Manzalawy and Chen
datasets.
Additional file 2: SVM parameter optimizationDescription of Data:
Training sets from EL-Manzalawy and Chen datasets were trained under
10-fold cross-validation using various C and g values. Optimal set of C
and g values for each peptide representation is indicated below the plot.
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